Indications and uses
for the temporary relief of minor aches and pains due to: • Headache • Muscular aches • Backache • Minor pain of arthritis • The common cold • Toothache • Premenstrual and menstrual cramps Temporarily reduces fever.
for the temporary relief of minor aches and pains due to: • Headache • Muscular aches • Backache • Minor pain of arthritis • The common cold • Toothache • Premenstrual and menstrual cramps Temporarily reduces fever.
Do not take more than directed AGE DOSE Adults and children 12 years and over • Take 2 tablets every 4 to 6 hours while symptoms last • Do not take more than 12 tablets in 24 hours Children 6 to 11 years • Take 1 tablet every 4 to 6 hours while symptoms last • Do not take more than 5 tablets in 24 hours Children under 6 years Do not use adult Regular Strength products in children under 6 year...
Acetaminophen 325 mg
Pain reliever/fever reducer
Aspirin-Free Pain Reliever/ Fever Reducer
for the temporary relief of minor aches and pains due to:
Temporarily reduces fever.
Liver warning: This product contains acetaminophen. Severe liver damage may occur if
liver disease.
taking the blood thinning drug warfarin.
These could be signs of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Do not take more than directed
AGE | DOSE |
Adults and children 12 years and over |
|
Children 6 to 11 years |
|
Children under 6 years | Do not use adult Regular Strength products in children under 6 years of age; this will provide more than the recommended dose (overdose) of acetaminophen and may cause liver damage. |
Povidone, Pregelatinized Starch, Sodium Starch Glycolate, Stearic Acid
Adverse Drug Event call (800) 616-2471
Tamper Evident: Do not use if sealed blister units are broken or damaged.
LHC54731216
Distributed by:
MAJOR® PHARMACEUTICALS
17177 N Laurel Park Dr., Suite 233
Livonia, MI 48152 USA
Product: 50436-3220
NDC: 50436-3220-3 24 TABLET in a BOTTLE
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 313782 | acetaminophen 325 MG Oral Tablet | PSN | 8 |
| 209375 | MAPAP 325 MG Oral Tablet | PSN | 8 |
| 209375 | acetaminophen 325 MG Oral Tablet [Mapap] | SBD | 8 |
| 313782 | acetaminophen 325 MG Oral Tablet | SCD | 8 |
| 313782 | APAP 325 MG Oral Tablet | SY | 8 |
| 209375 | APAP 325 MG Oral Tablet [Mapap] | SY | 8 |
| 209375 | Mapap 325 MG Oral Tablet | SY | 8 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50436-3220-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4b71-a910-e053-dadaa90a0b85 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50436-3220-3 | Mapap | 24 in 1 BOTTLE | TABLET | 24 | 8 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50436-3220 | MAPAP (ACETAMINOPHEN) TABLET [UNIT DOSE SERVICES] | 8 | Legacy NDC, 1 package rows | 20171108_5a7fe4a5-e1cd-49a9-9b91-6ff009e1dd26.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-1982-51 | EA - Each | 0904-1982 | d1f0fa3d-d768-4a49-a185-2ac685e3c890 | 1 | 2013-02-11 |
| 0904-1982-59 | EA - Each | 0904-1982 | a24472eb-cf1e-4286-a017-9b42d265de73 | 1 | 2013-02-11 |
| 0904-1982-60 | EA - Each | 0904-1982 | cf37093b-6a2f-46ec-ace3-b8236093ba0f | 1 | 2013-02-11 |
| 0904-1982-61 | EA - Each | 0904-1982 | 402a4b9b-2be1-45c4-a1d9-316f155ac908 | 1 | 2012-07-24 |
| 0904-1982-80 | EA - Each | 0904-1982 | ea47e96c-011a-4315-be09-7f12254d47fa | 1 | 2013-02-11 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | 4 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | 4 | |
| POVIDONE K12 | INACTIVE INGREDIENT | 333AG72FWJ | 4 | |
| SODIUM STARCH GLYCOLATE TYPE A CORN | INACTIVE INGREDIENT | AG9B65PV6B | 4 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 4 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50436-3220 | 50436-3220-3 |
| 0904-1982 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| POVIDONE K12 | 333AG72FWJ | IACT |
| SODIUM STARCH GLYCOLATE TYPE A CORN | AG9B65PV6B | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | INJECTION / INTRAVENOUS | 648 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING / ORAL | 100 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / ORAL | 336 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, DELAYED RELEASE / ORAL | 713 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE / ORAL | 5785 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | PASTILLE / ORAL | NA | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, COATED / ORAL | 256 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, EXTENDED RELEASE / ORAL | 194 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, DELAYED RELEASE / ORAL | 216 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 21 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, EXTENDED RELEASE / ORAL | 184 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / SUBLINGUAL | 409 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION, EXTENDED RELEASE / ORAL | 113 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | POWDER, FOR SUSPENSION / ORAL | 34 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | INJECTION, SUSPENSION / INTRAVENOUS | 0.08 %w/v | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, CHEWABLE / ORAL | 180 mg | ||
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | INJECTION / SUBCUTANEOUS | 20 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION / ORAL | 900 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION/ DROPS / ORAL | 90 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / BUCCAL | 16.6 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | DROPS / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 600 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | INSERT / VAGINAL | 147 mg | ||
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | TABLET / ORAL | 173 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CONCENTRATE / ORAL | NA | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | SOLUTION, CONCENTRATE / INTRAVENOUS | 1000 mg | ||
| POVIDONE K12 | POVIDONE K12 | 333AG72FWJ | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.2 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b09e920c-deb1-4be9-8f7a-9e20764a3921 | 5a7fe4a5-e1cd-49a9-9b91-6ff009e1dd26 | 2017-11-07 | Warnings | b09e920c-deb1-4be9-8f7a-9e20764a3921 5a7fe4a5-e1cd-49a9-9b91-6ff009e1dd26 |
Adverse event summaries are temporarily unavailable. Other product information remains available.